Feature Channels: Cell Biology

Filters close
Released: 14-Apr-2023 11:45 AM EDT
Benefits of “zombie” cells: Senescent cells aid regeneration in salamanders
Technische Universität Dresden

Senescent cells are cells that have permanently stopped dividing in response to cellular stress but have not died. As organisms age, the number of senescent cells in the body increases.

Newswise: Safe Bioink for Artificial Organ Printing
Released: 14-Apr-2023 12:00 AM EDT
Safe Bioink for Artificial Organ Printing
National Research Council of Science and Technology

Dr. Song Soo-chang's research team at the Center for Biomaterials, Korea Institute of Science and Technology (KIST, President Yoon Seok-jin), revealed the first development of poly(organophosphazene) hydrogel-based temperature-sensitive bioink that stably maintained its physical structure only by temperature control without photocuring, induced tissue regeneration, and then biodegraded in the body after a certain period of time.

Released: 13-Apr-2023 4:00 PM EDT
Hallmarks to improving pancreatic cancer therapy identified by UCI researchers
University of California, Irvine

Scientists from the University of California, Irvine, the University of Michigan and the University of Texas MD Anderson Cancer Center have made a significant contribution to the field of pancreatic cancer research. Their new study presents several crucial themes in the biology of pancreatic cancer that can serve as hallmarks for pancreatic cancer therapy.

Newswise: Hairs that help fish feel–and humans hear
Released: 13-Apr-2023 12:05 PM EDT
Hairs that help fish feel–and humans hear
Case Western Reserve University

Brian McDermott, a Case Western Reserve scientist, is reporting a discovery about unexpected asymmetry on the hair cells of zebrafish that allow them to detect movement with greater sensitivity from the back than the front. “This shows that fish have hair cells that are actually tuned to sense different water directions,” McDermott said. “In humans, our cochleas have hair cells that are similarly tuned to be able to hear different frequencies.” McDermott said the finding also advances our understanding of “the long-sought mechanotransduction (Mec) channel” in living creatures.

   
Released: 13-Apr-2023 10:20 AM EDT
Shapeshifters: Can buildings behave like organisms?
Cornell University

A team of Cornell researchers and their colleagues want to learn how to fix cardiac malformations by analyzing brain cancer or plants with a five-year, $3 million grant from the National Science Foundation.

   
Released: 12-Apr-2023 6:25 PM EDT
From tragedy, a new potential cancer treatment
Cold Spring Harbor Laboratory

Diffuse intrinsic pontine glioma (DIPG) is a lethal pediatric brain cancer that often kills within a year of diagnosis. Surgery is almost impossible because of the tumors’ location. Chemotherapy has debilitating side effects. New treatment options are desperately needed.

Newswise: Research identifies new target that may prevent blood cancer
Released: 12-Apr-2023 4:50 PM EDT
Research identifies new target that may prevent blood cancer
Vanderbilt University Medical Center

An international coalition of biomedical researchers co-led by Alexander Bick, MD, PhD, at Vanderbilt University Medical Center has determined a new way to measure the growth rate of precancerous clones of blood stem cells that one day could help doctors lower their patients’ risk of blood cancer. The technique, called PACER, led to the identification of a gene that, when activated, drives clonal expansion.

Newswise: Cancer cells penetrate deep into their environment
Released: 12-Apr-2023 4:20 PM EDT
Cancer cells penetrate deep into their environment
Washington University in St. Louis

New research from the McKelvey School of Engineering at Washington University in St. Louis has found that cancer cells can sense a layer of cells beneath the top collagen layer on which they normally travel, while normal cells cannot.

Newswise: New Technique Allows Researchers to Dig into Molecular Causes of Pediatric Bipolar Disorder
Released: 12-Apr-2023 2:35 PM EDT
New Technique Allows Researchers to Dig into Molecular Causes of Pediatric Bipolar Disorder
University of Utah Health

Coaxing blood cells from patients to develop into three-dimensional brain “organoids” is allowing scientists at University of Utah Health to gain insights into pediatric bipolar disorder.

Newswise: When cells sense the cue for growth
Released: 12-Apr-2023 1:05 PM EDT
When cells sense the cue for growth
Tokyo Metropolitan Institute of Medical Science

Researchers of the Genome Dynamics Project team at Tokyo Metropolitan Institute of Medical Science ·revealed new mechanism controlling cellular proliferation in response to serum, which triggers growth of resting cells.

Newswise: Whether Physical Exertion Feels ‘Easy’ or ‘Hard’ May Be Due to Dopamine Levels, Study Suggests
Released: 12-Apr-2023 1:00 PM EDT
Whether Physical Exertion Feels ‘Easy’ or ‘Hard’ May Be Due to Dopamine Levels, Study Suggests
Johns Hopkins Medicine

Dopamine, a brain chemical long associated with pleasure, motivation and reward-seeking, also appears to play an important role in why exercise and other physical efforts feel “easy” to some people and exhausting to others, according to results of a study of people with Parkinson’s disease led by Johns Hopkins Medicine researchers. Parkinson’s disease is marked by a loss of dopamine-producing cells in the brain over time.

Released: 12-Apr-2023 1:00 PM EDT
Study compares de novo proteins with randomly produced proteins
University of Münster

Proteins are components of every cell. How they have changed in the course of evolution for the purpose of taking on new functions in the body, has long been a subject of research.

Newswise: Cedars-Sinai Cancer Collaborates on a New Type of Clinical Trial
Released: 12-Apr-2023 12:45 PM EDT
Cedars-Sinai Cancer Collaborates on a New Type of Clinical Trial
Cedars-Sinai

Investigators from Cedars-Sinai Cancer are collaborating on a streamlined clinical trial design in a study called Pragmatica-Lung.

Released: 12-Apr-2023 12:35 PM EDT
AACR 2023: Ohio State experts share new findings on immuno-oncology, ‘smart-drugs,’ obesity-related endometrial cancers and other research topics
Ohio State University Wexner Medical Center

New smart-drug treatment options for pancreatic cancer, immuno-oncology treatments and real-time immune-monitoring strategies are among the research topics to be presented by investigators at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) at the American Association for Cancer Research (AACR) annual meeting held April 14-19 at the Orange County Convention Center in Orlando, Florida.

Released: 12-Apr-2023 12:00 PM EDT
MD Anderson Research Highlights: AACR 2023 Special Edition
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. This special edition features presentations by MD Anderson researchers at the American Association for Cancer Research (AACR) Annual Meeting 2023.

   
Newswise: New Study Flips the Script on Liver Cancer
Released: 12-Apr-2023 11:00 AM EDT
New Study Flips the Script on Liver Cancer
University of California San Diego

UC San Diego scientists find a protein associated with liver cancer may actually be the key to protecting against it. By blocking ferroptosis, a form of liver cell death, the protein prevents liver damage and its progression to cancer.

7-Apr-2023 8:00 AM EDT
Testing vaccine candidates quickly with lab-grown mini-organs
American Chemical Society (ACS)

Researchers reporting in ACS Central Science have developed a new testing platform that encapsulates B cells — some of the most important components of the immune system — into miniature “organoids” to make vaccine screening quicker and greatly reduce the number of animals needed for testing.

   
Released: 11-Apr-2023 6:05 PM EDT
Study offers insights into how COVID variants escape immune system ‘killers’
Yale University

Omicron subvariants of SARS-CoV-2 — the virus behind COVID-19 — have shown an uncanny knack for evading antibodies produced either by vaccines or exposure to earlier versions of the virus, leading to many breakthrough infections. However, in order to sicken people, these viral variants must also avoid “killer” T cells, immune cells that are unleashed when the immune system detects foreign pathogens.

Newswise: Cutting-edge imaging: Live protein secretion visualized with nano-optics
Released: 11-Apr-2023 1:05 PM EDT
Cutting-edge imaging: Live protein secretion visualized with nano-optics
École Polytechnique Fédérale de Lausanne (EPFL)

Cell secretions like proteins, antibodies, and neurotransmitters play an essential role in immune response, metabolism, and communication between cells.

   
Released: 11-Apr-2023 12:00 PM EDT
Four Penn Medicine Abramson Cancer Center Researchers Receive Top AACR Awards
Perelman School of Medicine at the University of Pennsylvania

Four distinguished researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will receive 2023 Scientific Achievement Awards from the American Association for Cancer Research (AACR), during the AACR Annual Meeting 2023.

Released: 11-Apr-2023 8:05 AM EDT
Could a Novel Small Molecule Slow or Reverse the Effects of Duchenne Muscular Dystrophy?
Federation of American Societies for Experimental Biology (FASEB)

In a new study published in The FASEB Journal, investigators demonstrated the potential of a molecule that may help overcome some of the devastating symptoms of Duchenne muscular dystrophy (DMD), the most common life-limiting congenital neuromuscular disorder. The agent promotes the activity of AMP-activated protein kinase (AMPK), an important fuel-sensing enzyme that is present in all mammalian cells.

   
Released: 10-Apr-2023 3:15 PM EDT
Prior treatments influence immunotherapy response in advanced melanoma
University of California, Los Angeles (UCLA), Health Sciences

Research led by scientists at UCLA Jonsson Comprehensive Cancer Center found that responses to a type of immunotherapy called PD-1 checkpoint blockade in patients with advanced melanoma depended on whether or not they had previously received another immunotherapy – CTLA-4 blockade – as well as other factors.

Newswise: Scientists Enhance New Neurons to Restore Memory, Elevate Mood in Alzheimer’s Disease Research Model
Released: 10-Apr-2023 1:45 PM EDT
Scientists Enhance New Neurons to Restore Memory, Elevate Mood in Alzheimer’s Disease Research Model
University of North Carolina School of Medicine

UNC School of Medicine scientists demonstrated that stimulating a brain region called Supramammilary nucleus (SuM) located in the hypothalamus effectively enhanced adult-born neurons in the otherwise impaired Alzheimer’s brains of mice.

Newswise: Yale Cancer Center experts to present new research at annual AACR Meeting
Released: 10-Apr-2023 7:05 AM EDT
Yale Cancer Center experts to present new research at annual AACR Meeting
Yale Cancer Center/Smilow Cancer Hospital

Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH) physicians and scientists are presenting research studies at the 2023 American Association for Cancer Research (AACR) Annual Meeting at the Orange County Convention Center in Orlando, Florida, April 14 to 19th.

Newswise: Study sheds light on how IBD can develop
Released: 7-Apr-2023 5:35 PM EDT
Study sheds light on how IBD can develop
University of California, Riverside

Inflammatory bowel disease, or IBD, describes Crohn’s disease and ulcerative colitis, two chronic diseases that cause inflammation in the intestines. IBD, which affects about 3 million adults in the United States, is an autoimmune disorder — a condition in which the body’s immune system attacks healthy tissues.

Newswise: Woolly mammoths evolved smaller ears and woolier coats over the 700,000 years that they roamed the Siberian steppes
Released: 7-Apr-2023 4:15 PM EDT
Woolly mammoths evolved smaller ears and woolier coats over the 700,000 years that they roamed the Siberian steppes
Cell Press

A team of researchers compared the genomes of woolly mammoths with modern day elephants to find out what made woolly mammoths unique, both as individuals and as a species. The investigators report April 7 in the journal Current Biology that many of the woolly mammoth’s trademark features—including their woolly coats and large fat deposits—were already genetically encoded in the earliest woolly mammoths, but these and other traits became more defined over the species’ 700,000+ year existence.

Newswise: “We were dancing around the lab” – cellular identity discovery has potential to impact cancer treatments
Released: 7-Apr-2023 3:45 PM EDT
“We were dancing around the lab” – cellular identity discovery has potential to impact cancer treatments
Trinity College Dublin

A team of scientists led by those in Trinity College Dublin has discovered new mechanisms involved in establishing cellular identity, a process that ensures the billions of different cells in our bodies do the correct job.

Released: 7-Apr-2023 2:20 PM EDT
Study reveals epigenetic vulnerability of acute myeloid leukemia
Baylor College of Medicine

Acute myeloid leukemia (AML) is an aggressive blood cancer that causes uncontrolled accumulation of white blood cells. Because of the poor outcomes of this disease, researchers across the globe have been on the hunt for new ways to treat AML, while preserving normal blood development.

3-Apr-2023 3:30 PM EDT
CHOP-led Study Identifies Two Different Regulatory T Cell Populations
Children's Hospital of Philadelphia

A regulatory class of human T cells descends from two different origins, one that relates to autoimmunity and one that relates to protective immunity, according to a new study led by Children’s Hospital of Philadelphia (CHOP). The findings, published today in Science Immunology, could pave the way for new treatments for autoimmune diseases that target the immune system selectively.

Newswise: Blind dating in bacteria evolution
Released: 6-Apr-2023 7:20 PM EDT
Blind dating in bacteria evolution
Max Planck Society (Max-Planck-Gesellschaft)

Proteins are the key players for virtually all molecular processes within the cell. To fulfil their diverse functions, they have to interact with other proteins. Such protein-protein interactions are mediated by highly complementary surfaces, which typically involve many amino acids that are positioned precisely to produce a tight, specific fit between two proteins. However, comparatively little is known about how such interactions are created during evolution.

Newswise: Researchers create embryo-like structures from monkey embryonic stem cells for the first time
Released: 6-Apr-2023 7:00 PM EDT
Researchers create embryo-like structures from monkey embryonic stem cells for the first time
Cell Press

Human embryo development and early organ formation remain largely unexplored due to ethical issues surrounding the use of embryos for research as well as limited availability of materials to study.

   
Released: 6-Apr-2023 3:10 PM EDT
Fred Hutch at AACR: New targets for cancer therapies, experts available in diversity and cancer screening tests — and Fred Hutch’s Philip Greenberg becomes AACR president
Fred Hutchinson Cancer Center

Experts from Fred Hutchinson Cancer Center will present their latest findings on targets in RIT1-driven cancers, ROR1 CAR T-cell immunotherapy, interplay of the microbiome and genetics in colorectal cancer and more at the annual meeting of the American Association for Cancer Research, to be held April 14-19 in Orlando, Florida.

   
Released: 6-Apr-2023 10:00 AM EDT
ASBMB urges NIAID to prioritize DEAI
American Society for Biochemistry and Molecular Biology (ASBMB)

ASBMB calls upon NIAID to expand the use of research supplements, support scientists with disabilities and those in the LGBTQ+ community

Released: 5-Apr-2023 7:30 PM EDT
Researchers discover key pathway for COVID organ damage in adults
Emory Health Sciences

Even after three years since the emergence of COVID-19, much remains unknown about how it causes severe disease, including the widespread organ damage beyond just the lungs. Increasingly, scientists are learning that organ dysfunction results from damage to the blood vessels, but why the virus causes this damage is unclear.

Newswise: Lab-Grown Fat Could Give Cultured Meat Real Flavor and Texture
Released: 5-Apr-2023 6:15 PM EDT
Lab-Grown Fat Could Give Cultured Meat Real Flavor and Texture
Tufts University

Researchers have developed a method to produce fat tissue grown from cells at large scale. The cultured fat will help add flavor and texture to cultured meat that more closely replicates the look, feel and taste of meat derived from farm animals.

Newswise: Humans vs. Bacteria: Differences in Ribosome Decoding Revealed
Released: 5-Apr-2023 11:05 AM EDT
Humans vs. Bacteria: Differences in Ribosome Decoding Revealed
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital have found that human ribosomes decode mRNA slower than bacteria, with implications for drug development.

3-Apr-2023 3:00 PM EDT
CHOP Researchers Reveal Complex Assembly Process Involved in DNA Virus Replication
Children's Hospital of Philadelphia

In a twist on the question, “Which came first, the chicken or the egg?”, scientists have long faced a similar question about how human adenovirus replicates: “Which comes first, assembly of the viral particle, or packaging of the viral genome?” Now, in a new study published today in Nature, researchers at Children’s Hospital of Philadelphia (CHOP) have answered that question, showing that viral proteins use a process called phase separation to coordinate production of viral progeny.

Newswise: University of Oregon’s Diana Libuda Receives FASEB Excellence in Science Award
Released: 5-Apr-2023 10:35 AM EDT
University of Oregon’s Diana Libuda Receives FASEB Excellence in Science Award
Federation of American Societies for Experimental Biology (FASEB)

The Federation of American Societies for Experimental Biology awarded Diana Libuda, PhD, Associate Professor of Biology at the University of Oregon Institute of Molecular Biology, with the Excellence in Science Early-career Investigator Award.

   
Newswise: NIH’s Elaine Jaffe Receives FASEB Excellence in Science Award
Released: 5-Apr-2023 10:05 AM EDT
NIH’s Elaine Jaffe Receives FASEB Excellence in Science Award
Federation of American Societies for Experimental Biology (FASEB)

The Federation of American Societies for Experimental Biology (FASEB) awarded Elaine S. Jaffe, MD, Distinguished Investigator at the National Institutes of Health’s National Cancer Institute (NCI), with the Excellence in Science Lifetime Achievement Award.

   
Newswise: Harvard University’s Paola Arlotta Receives FASEB Excellence in Science Award
Released: 5-Apr-2023 10:05 AM EDT
Harvard University’s Paola Arlotta Receives FASEB Excellence in Science Award
Federation of American Societies for Experimental Biology (FASEB)

The Federation of American Societies for Experimental Biology (FASEB) awarded Paola Arlotta, PhD, Professor of Stem Cell and Regenerative Biology at Harvard University, with its Excellence in Science Mid-career Investigator Award.

   
Released: 5-Apr-2023 10:05 AM EDT
Announcing FASEB Excellence in Science Awards
Federation of American Societies for Experimental Biology (FASEB)

The Federation of American Societies for Experimental Biology (FASEB) announced the recipients of its 2023 Excellence in Science Awards. For more than 30 years, these awards have highlighted outstanding achievements by women in the biological sciences.

   
Newswise: Traumatic Brain Injury Interferes with Immune System Cells’ Recycling Process in Brain Cells
Released: 4-Apr-2023 1:10 PM EDT
Traumatic Brain Injury Interferes with Immune System Cells’ Recycling Process in Brain Cells
University of Maryland School of Medicine

In a new study published in the January issue of Autophagy, they found that after traumatic brain injury, the brain’s immune system cells’ internal recycling function slowed dramatically, allowing waste products to build up and interfere with recovery from injury.

Newswise: Study to decode microbe-gut signaling suggests potential new treatment for IBD
Released: 4-Apr-2023 1:00 PM EDT
Study to decode microbe-gut signaling suggests potential new treatment for IBD
Cincinnati Children's Hospital Medical Center

Fresh insights into how our bodies interact with the microbes living in our guts suggest that a two-drug combination may offer a new way to treat inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis.

Released: 3-Apr-2023 7:00 PM EDT
How do we know if our brain is capable of repairing itself?
Netherlands Institute for Neuroscience

Is our brain able to regenerate? And can we harness this regenerative potential during aging or in neurodegenerative conditions? These questions sparked intense controversy within the field of neuroscience for many years.

Released: 3-Apr-2023 6:40 PM EDT
Cells refine palm fat into olive oil
University of Bonn

Fat molecules serve as energy storage for fat cells. They consist of three fatty acids attached to a backbone of glycerol. They are therefore also called triglycerides. It has long been suspected that molecules do not remain unchanged during their storage period.

   
Newswise: Cold is beneficial for healthy aging
Released: 3-Apr-2023 6:15 PM EDT
Cold is beneficial for healthy aging
University of Cologne

Cold activates a cellular cleansing mechanism that breaks down harmful protein aggregations responsible for various diseases associated with aging.

Released: 3-Apr-2023 5:30 PM EDT
Jumping genes in cancer cells open door to new immunotherapies
Washington University in St. Louis

New research from Washington University School of Medicine in St. Louis suggests that transposable elements in various cancers potentially may be used to direct novel immunotherapies to tumors that don’t typically respond to immune-based treatments.



close
3.59134